Ensuring Compliance with Advertising and Promotional Requirements for Drugs and Medical Devices

  • Check with publisher
  • Published date: March 28, 2022
    • San Jose, California, United States

Federal regulation of the advertising and promotion of pharmaceuticals and medical devices reflects an aggressive attitude on the part of the regulators that demands, in turn, that industry be keenly aware of the legal and regulatory duties, as well as key recent trends in enforcement activities by the Federal Government. This course will explore in detail what FDA requires of drug and device firms as well as recent current hot buttons in FDA enforcement activity for the advertising arena.

What’s at stake if your advertising and promotional efforts violate the law? Colossal fines – the latest was $3 Billion; criminal liability, including even prison time; and huge disruption in operations while dealing with federal probes into illegal marketing.

Result 0 votes
Ashutos Swain
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Self-emulsifying Drug Delivery System Services

    Self-emulsifying Drug Delivery System Services

    Pharmacology - Drug Development (United States ) May 9, 2022 Check with publisher

    CD Formulation's self-emulsifying drug delivery system service can evaluate the bioavailability of drugs and suggest suitable product solutions. Our professional team has the ability to establish and validate analytical methods, determine oil/water p...

  • Encapsulation Techniques Services

    Encapsulation Techniques Services

    Pharmacology - Drug Development (United States ) May 9, 2022 Check with publisher

    Currently, more than 90% of small molecule new drug candidates have oral bioavailability issues. Solubility and bioavailability issues run through drug metabolism and pharmacokinetic evaluation of candidate compounds, preclinical prescription develop...